Project Grant K23MH137406
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $194,157 to the Icahn School of Medicine at Mount Sinai to develop and pilot a novel intervention to treat post-COVID cognitive impairment and depression in patients. The intervention integrates cognitive rehabilitation based on goal management training and cognitive behavioral therapy, and is specifically adapted for ethnically diverse patients....
- This federal Project Grant award, funded by the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), supports a $792,006 research study on suicidality in autistic adults. The study aims to comprehensively examine the relationships between adversity, trauma, and protective factors in predicting suicidal ideation and behaviors in a sample of 250 autistic adults aged 18-40, with at least half being at high-risk for suicide. The longitudinal study...
- This $154,484 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support a study investigating the roles of social reward responsiveness and interpersonal stress as predictors of suicidal ideation in sexual and gender minority (SGM) youth. The study will assess these risk factors in a sample of 210 adolescents (aged 13-17) following acute psychiatric treatment for self-injurious thoughts and behaviors....
- This federal Project Grant award of $185,552.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to examine the neurocognitive and social factors underlying suicide risk in adolescent girls. The key objectives are to investigate two forms of sustained neurocognitive responsivity to social threat that may disrupt social connectedness and increase suicidal thoughts and behaviors in this population. The research will...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $661,237 over 5 years to The Ohio State University to conduct research on optimizing brief coping skills interventions for suicide prevention. The study aims to intensively characterize the contexts in which patients at high risk for suicide are most likely to use and benefit from their safety planning interventions, leveraging technology and...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $923,552 to Unmute Enterprise Inc. to develop and evaluate the Culturally Affirming Racial Equity (CARE) Framework. The CARE Framework is an innovative, process-focused, and modular approach that aims to strengthen the therapeutic alliance and reduce treatment disparities for racial/ethnic minority patients seeking mental health services. The key...
- The National Institute of Mental Health (NIMH) awarded a $854,029 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction." The award, effective September 1, 2025 and running through August 31, 2030, will fund the development and evaluation of a multimodal...
- The National Institute of Mental Health (NIMH) awarded a 4-year, $1,549,649 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Rutgers, The State University in New Jersey. The goal of this research project is to leverage a multimodal assessment of behavioral and social mechanisms to improve the ability to identify specific predictors relating social disconnection to suicidal ideation in older adults. The project will examine how rejection sensitivity moderates the...
- This $145,989 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the CFDA program "Research Related to Deafness and Communication Disorders", will support research to investigate the neural basis of tinnitus and hyperacusis (hearing conditions characterized by ringing in the ears and hypersensitivity to sound, respectively). The research team at the University of Rochester will use advanced in vivo imaging techniques,...
- This $793,161 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year experimental study to investigate the relationship between nocturnal wakefulness and suicide risk factors. The University of Arizona, the prime awardee, will recruit 90 adults with recent suicidal ideation to participate in laboratory-based assessments of cognitive processes and affect at different times of day, as well as...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is for a study to develop and test a cognitive behavioral therapy intervention to improve treatment engagement and reduce suicide risk among deaf individuals. The $174,381 award, with a project period from September 1, 2025 to August 31, 2029, will be used by the University of Rochester to achieve three key objectives: 1) gain expertise in conducting randomized controlled trials with deaf individuals, 2) acquire knowledge and skills for research on subjects at elevated suicide risk, and 3) develop implementation science methods to support deployment-ready interventions. The research aims to develop an interventionist training and monitoring program for Cognitive Behavioral Therapy for Treatment-Seeking for Deaf Individuals, and conduct a randomized controlled trial to examine its impact on beliefs about treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $174.4k | 8/27/25 |